Geftib 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Glenmark Pharmaceuticals Ltd
  4. Geftib 250 mg Tablet

Geftib 250 mg Tablet

Geftib 250 mg Tablet contains gefitinib 250 mg and is an oral anticancer medicine used for the treatment of non-small cell lung cancer. It is taken by mouth with or without food according to the prescribed treatment plan. Gefitinib blocks EGFR signaling, which can help slow the growth of cancer cells.

BUY NOW

Category

Geftib is an EGFR tyrosine kinase inhibitor used for adults with appropriate EGFR-mutated non-small cell lung cancer. By inhibiting EGFR signaling, it interferes with pathways involved in cancer-cell growth and survival. The usual recommended strength is 250 mg once daily, with treatment continued according to the oncologist’s assessment and response. Patients may require monitoring for diarrhea, skin reactions, liver abnormalities, breathing difficulties, and other clinically important adverse effects.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Recommended Dose 250 mg once daily
Marketer Glenmark Pharmaceuticals Ltd

Product Also Known As

Geftib 250mg Tablet, Geftib 250 mg Tablet, Gefitinib 250mg Tablet, Gefitinib 250 mg Tablet, Gefitinib Tablets 250mg, Gefitinib EGFR Inhibitor Tablet